194 related articles for article (PubMed ID: 35244890)
21. GRP78 in lung cancer.
Xia S; Duan W; Liu W; Zhang X; Wang Q
J Transl Med; 2021 Mar; 19(1):118. PubMed ID: 33743739
[TBL] [Abstract][Full Text] [Related]
22. The novel HSP90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines.
McCleese JK; Bear MD; Fossey SL; Mihalek RM; Foley KP; Ying W; Barsoum J; London CA
Int J Cancer; 2009 Dec; 125(12):2792-801. PubMed ID: 19544563
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional repression of the prosurvival endoplasmic reticulum chaperone GRP78/BIP by E2F1.
Racek T; Buhlmann S; Rüst F; Knoll S; Alla V; Pützer BM
J Biol Chem; 2008 Dec; 283(49):34305-14. PubMed ID: 18840615
[TBL] [Abstract][Full Text] [Related]
24. Targeting HSP70 chaperones by rhein sensitizes liver cancer to artemisinin derivatives.
Wang J; Zhang J; Guo Z; Hua H; Zhang H; Liu Y; Jiang Y
Phytomedicine; 2024 Jan; 122():155156. PubMed ID: 37897861
[TBL] [Abstract][Full Text] [Related]
25. Sequential interaction of the chaperones BiP and GRP94 with immunoglobulin chains in the endoplasmic reticulum.
Melnick J; Dul JL; Argon Y
Nature; 1994 Aug; 370(6488):373-5. PubMed ID: 7913987
[TBL] [Abstract][Full Text] [Related]
26. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.
Fu Y; Li J; Lee AS
Cancer Res; 2007 Apr; 67(8):3734-40. PubMed ID: 17440086
[TBL] [Abstract][Full Text] [Related]
27. AR-12 Inhibits Multiple Chaperones Concomitant With Stimulating Autophagosome Formation Collectively Preventing Virus Replication.
Booth L; Roberts JL; Ecroyd H; Tritsch SR; Bavari S; Reid SP; Proniuk S; Zukiwski A; Jacob A; Sepúlveda CS; Giovannoni F; García CC; Damonte E; González-Gallego J; Tuñón MJ; Dent P
J Cell Physiol; 2016 Oct; 231(10):2286-302. PubMed ID: 27187154
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor.
Al-Hashimi AA; Lebeau P; Majeed F; Polena E; Lhotak Š; Collins CAF; Pinthus JH; Gonzalez-Gronow M; Hoogenes J; Pizzo SV; Crowther M; Kapoor A; Rak J; Gyulay G; D'Angelo S; Marchiò S; Pasqualini R; Arap W; Shayegan B; Austin RC
J Biol Chem; 2017 Dec; 292(51):21180-21192. PubMed ID: 29066620
[TBL] [Abstract][Full Text] [Related]
29. OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killing.
Booth L; Cazanave SC; Hamed HA; Yacoub A; Ogretmen B; Chen CS; Grant S; Dent P
Cancer Biol Ther; 2012 Feb; 13(4):224-36. PubMed ID: 22354011
[TBL] [Abstract][Full Text] [Related]
30. Cellular Transcriptomics of Carboplatin Resistance in a Metastatic Canine Osteosarcoma Cell Line.
Hodge MA; Miller T; Weinman MA; Wustefeld-Janssens B; Bracha S; Davis BW
Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980828
[TBL] [Abstract][Full Text] [Related]
31. Selective Inactivation of Intracellular BiP/GRP78 Attenuates Endothelial Inflammation and Permeability in Acute Lung Injury.
Leonard A; Grose V; Paton AW; Paton JC; Yule DI; Rahman A; Fazal F
Sci Rep; 2019 Feb; 9(1):2096. PubMed ID: 30765717
[TBL] [Abstract][Full Text] [Related]
32. ATF4 destabilizes RET through nonclassical GRP78 inhibition to enhance chemosensitivity to bortezomib in human osteosarcoma.
Luo J; Xia Y; Yin Y; Luo J; Liu M; Zhang H; Zhang C; Zhao Y; Yang L; Kong L
Theranostics; 2019; 9(21):6334-6353. PubMed ID: 31534554
[No Abstract] [Full Text] [Related]
33. Long Interleukin-22 Binding Protein Isoform-1 Is an Intracellular Activator of the Unfolded Protein Response.
Gómez-Fernández P; Urtasun A; Paton AW; Paton JC; Borrego F; Dersh D; Argon Y; Alloza I; Vandenbroeck K
Front Immunol; 2018; 9():2934. PubMed ID: 30619294
[TBL] [Abstract][Full Text] [Related]
34. Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells.
Virrey JJ; Dong D; Stiles C; Patterson JB; Pen L; Ni M; Schönthal AH; Chen TC; Hofman FM; Lee AS
Mol Cancer Res; 2008 Aug; 6(8):1268-75. PubMed ID: 18708359
[TBL] [Abstract][Full Text] [Related]
35. Exosomal proteomic signatures correlate with drug resistance and carboplatin treatment outcome in a spontaneous model of canine osteosarcoma.
Weinman MA; Ramsey SA; Leeper HJ; Brady JV; Schlueter A; Stanisheuski S; Maier CS; Miller T; Ruby CE; Bracha S
Cancer Cell Int; 2021 May; 21(1):245. PubMed ID: 33933069
[TBL] [Abstract][Full Text] [Related]
36. The interaction between RUNX2 and core binding factor beta as a potential therapeutic target in canine osteosarcoma.
Alegre F; Ormonde AR; Godinez DR; Illendula A; Bushweller JH; Wittenburg LA
Vet Comp Oncol; 2020 Mar; 18(1):52-63. PubMed ID: 31381810
[TBL] [Abstract][Full Text] [Related]
37. Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
McMahon MB; Bear MD; Kulp SK; Pennell ML; London CA
Am J Vet Res; 2010 Jul; 71(7):799-808. PubMed ID: 20594083
[TBL] [Abstract][Full Text] [Related]
38. Glucosamine-induced endoplasmic reticulum stress promotes ApoB100 degradation: evidence for Grp78-mediated targeting to proteasomal degradation.
Qiu W; Kohen-Avramoglu R; Mhapsekar S; Tsai J; Austin RC; Adeli K
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):571-7. PubMed ID: 15618547
[TBL] [Abstract][Full Text] [Related]
39. Human cytomegalovirus specifically controls the levels of the endoplasmic reticulum chaperone BiP/GRP78, which is required for virion assembly.
Buchkovich NJ; Maguire TG; Yu Y; Paton AW; Paton JC; Alwine JC
J Virol; 2008 Jan; 82(1):31-9. PubMed ID: 17942541
[TBL] [Abstract][Full Text] [Related]
40. Expression and phosphorylation of BiP/GRP78, a molecular chaperone in the endoplasmic reticulum, during the differentiation of a mouse myeloblastic cell line.
Nakai A; Kawatani T; Ohi S; Kawasaki H; Yoshimori T; Tashiro Y; Miyata Y; Yahara I; Satoh M; Nagata K
Cell Struct Funct; 1995 Feb; 20(1):33-9. PubMed ID: 7796466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
